目次

TABLE OF CONTENTS

1 INTRODUCTION (Page No. - 40)
1.1 STUDY OBJECTIVES
1.2 MARKET DEFINITION
1.2.1 INCLUSIONS AND EXCLUSIONS
1.2.2 MARKETS COVERED
FIGURE 1 SINGLE CELL ANALYSIS INDUSTRY SEGMENTATION
1.2.3 YEARS CONSIDERED
1.3 CURRENCY
1.4 LIMITATIONS
1.5 STAKEHOLDERS
1.6 SUMMARY OF CHANGES
1.6.1 RECESSION IMPACT

2 RESEARCH METHODOLOGY (Page No. - 46)
2.1 RESEARCH APPROACH
FIGURE 2 RESEARCH DESIGN
2.1.1 SECONDARY RESEARCH
2.1.2 PRIMARY RESEARCH
FIGURE 3 SINGLE CELL ANALYSIS MARKET: PRIMARY RESPONDENTS
2.2 MARKET ESTIMATION METHODOLOGY
FIGURE 4 MARKET SIZE ESTIMATION: SUPPLY-SIDE ANALYSIS, 2022
FIGURE 5 MARKET SIZE ESTIMATION: APPROACH 1 (COMPANY REVENUE ANALYSIS-BASED ESTIMATION), 2022
2.2.1 INSIGHTS FROM PRIMARY EXPERTS
FIGURE 6 INSIGHTS ON MARKET FROM PRIMARY EXPERTS
2.3 MARKET GROWTH RATE PROJECTIONS
FIGURE 7 MARKET GROWTH RATE PROJECTION, 2023-2028
FIGURE 8 SINGLE CELL ANALYSIS INDUSTRY: GROWTH ANALYSIS OF DEMAND-SIDE FACTORS
2.4 DATA TRIANGULATION
FIGURE 9 DATA TRIANGULATION METHODOLOGY
2.5 RESEARCH ASSUMPTIONS
2.6 RISK ANALYSIS
2.7 RECESSION IMPACT
TABLE 1 GLOBAL INFLATION RATE PROJECTIONS, 2021-2027 (% GROWTH)

3 EXECUTIVE SUMMARY (Page No. - 56)
FIGURE 10 SINGLE CELL ANALYSIS MARKET, BY PRODUCT, 2023 VS. 2028 (USD MILLION)
FIGURE 11 SINGLE CELL ANALYSIS INDUSTRY, BY CELL TYPE, 2023 VS. 2028 (USD MILLION)
FIGURE 12 MARKET, BY TECHNIQUE, 2023 VS. 2028 (USD MILLION)
FIGURE 13 MARKET, BY APPLICATION, 2023 VS. 2028 (USD MILLION)
FIGURE 14 MARKET, BY END USER, 2023 VS. 2028 (USD MILLION)
FIGURE 15 GEOGRAPHICAL SNAPSHOT OF SINGLE CELL ANALYSIS INDUSTRY

4 PREMIUM INSIGHTS (Page No. - 61)
4.1 SINGLE CELL ANALYSIS MARKET OVERVIEW
FIGURE 16 TECHNOLOGICAL ADVANCEMENTS IN SINGLE-CELL ANALYSIS PRODUCTS TO DRIVE MARKET
4.2 NORTH AMERICA: SINGLE CELL ANALYSIS INDUSTRY SHARE, BY PRODUCT & COUNTRY (2022)
FIGURE 17 CONSUMABLES ACCOUNTED FOR LARGEST SHARE OF NORTH AMERICAN MARKET IN 2022
4.3 MARKET, BY PRODUCT, 2023 VS. 2028 (USD MILLION)
FIGURE 18 CONSUMABLES WILL CONTINUE TO DOMINATE MARKET IN 2028
4.4 MARKET SHARE, BY END USER, 2023 VS. 2028
FIGURE 19 ACADEMIC & RESEARCH LABORATORIES SEGMENT TO ACCOUNT FOR LARGEST MARKET SHARE IN 2023
4.5 MARKET: REGIONAL GROWTH OPPORTUNITIES
FIGURE 20 ASIA PACIFIC TO REGISTER HIGHEST GROWTH IN MARKET FROM 2023 TO 2028

5 MARKET OVERVIEW (Page No. - 64)
5.1 INTRODUCTION
5.2 MARKET DYNAMICS
FIGURE 21 SINGLE CELL ANALYSIS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
TABLE 2 SINGLE CELL ANALYSIS INDUSTRY: IMPACT ANALYSIS
5.2.1 DRIVERS
5.2.1.1 Technological advancements in single-cell analysis products
TABLE 3 RECENT TECHNOLOGICAL ADVANCEMENTS AND NEW PRODUCT LAUNCHES
5.2.1.2 Rising prevalence of cancer
TABLE 4 PROJECTED INCREASE IN NUMBER OF CANCER PATIENTS, 2015 VS. 2018 VS. 2020 VS. 2035
5.2.1.3 Increasing R&D in pharmaceutical & biotechnology industries for complex diseases
FIGURE 22 PHARMACEUTICAL R&D SPENDING, 2014-2028
5.2.1.4 Growth in stem cell research
5.2.1.5 Growing focus on personalized medicine
5.2.2 RESTRAINTS
5.2.2.1 High cost of single-cell analysis products
5.2.3 OPPORTUNITIES
5.2.3.1 High growth potential of single-cell sequencing
5.2.3.2 Integration of microfluidics in single-cell analysis
5.2.3.3 Emerging Asian markets
5.2.4 CHALLENGES
5.2.4.1 Standardization of protocols and data integration & quality control for developing cell therapies
5.3 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES
FIGURE 23 REVENUE SHIFT AND NEW POCKETS FOR SINGLE-CELL ANALYSIS PROVIDERS
5.4 INDICATIVE PRICING ANALYSIS
TABLE 5 AVERAGE PRICE RANGE OF SINGLE-CELL ANALYSIS PRODUCTS (2022)
TABLE 6 AVERAGE SELLING PRICE OF NGS SYSTEMS (2022)
5.5 VALUE CHAIN ANALYSIS
FIGURE 24 MAJOR VALUE ADDED DURING MANUFACTURING & ASSEMBLY PHASES
5.6 SUPPLY CHAIN ANALYSIS
FIGURE 25 SUPPLY CHAIN ANALYSIS OF MARKET
5.7 ECOSYSTEM ANALYSIS
FIGURE 26 ECOSYSTEM ANALYSIS: MARKET
TABLE 7 MARKET ECOSYSTEM
5.8 REGULATORY ANALYSIS
TABLE 8 REGULATORY SCENARIO
5.9 PORTER’S FIVE FORCES ANALYSIS
TABLE 9 MARKET: PORTER’S FIVE FORCES ANALYSIS
5.9.1 THREAT OF NEW ENTRANTS
5.9.2 THREAT OF SUBSTITUTES
5.9.3 BARGAINING POWER OF BUYERS
5.9.4 BARGAINING POWER OF SUPPLIERS
5.9.5 INTENSITY OF COMPETITIVE RIVALRY
5.10 KEY CONFERENCES & EVENTS IN 2023-2024
TABLE 10 MARKET: DETAILED LIST OF CONFERENCES & EVENTS
5.11 TECHNOLOGY ANALYSIS
TABLE 11 COMPARISON OF SINGLE-CELL ANALYSIS TECHNOLOGIES
5.12 KEY STAKEHOLDERS & BUYING CRITERIA
FIGURE 27 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS OF SINGLE-CELL ANALYSIS PRODUCTS
FIGURE 28 KEY BUYING CRITERIA FOR SINGLE-CELL ANALYSIS PRODUCTS
5.13 PATENT ANALYSIS
FIGURE 29 PATENTS GRANTED IN MARKET OVER LAST 10 YEARS
TABLE 12 INDICATIVE LIST OF PATENTS IN MARKET

6 SINGLE CELL ANALYSIS MARKET, BY PRODUCT (Page No. - 86)
6.1 INTRODUCTION
TABLE 13 SINGLE CELL ANALYSIS INDUSTRY, BY PRODUCT, 2021-2028 (USD MILLION)
6.2 CONSUMABLES
TABLE 14 SINGLE-CELL ANALYSIS CONSUMABLES MARKET, BY TYPE, 2021-2028 (USD MILLION)
TABLE 15 SINGLE-CELL ANALYSIS CONSUMABLES MARKET, BY REGION, 2021-2028 (USD MILLION)
TABLE 16 SINGLE-CELL ANALYSIS CONSUMABLES MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
6.2.1 BEADS
6.2.1.1 Wide application of beads in isolation of RNA and DNA to drive market
TABLE 17 SINGLE-CELL ANALYSIS BEADS MARKET, BY REGION, 2021-2028 (USD MILLION)
TABLE 18 SINGLE-CELL ANALYSIS BEADS MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
6.2.2 MICROPLATES
6.2.2.1 Increasing demand for genomic technologies to boost market
TABLE 19 SINGLE-CELL ANALYSIS MICROPLATES MARKET, BY REGION, 2021-2028 (USD MILLION)
TABLE 20 SINGLE-CELL ANALYSIS MICROPLATES MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
6.2.3 REAGENTS
6.2.3.1 Advancements in single-cell genomics to increase adoption of reagents
TABLE 21 SINGLE-CELL ANALYSIS REAGENTS MARKET, BY REGION, 2021-2028 (USD MILLION)
TABLE 22 SINGLE-CELL ANALYSIS REAGENTS MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
6.2.4 ASSAY KITS
TABLE 23 SINGLE-CELL ANALYSIS ASSAY KITS MARKET, BY TYPE, 2021-2028 (USD MILLION)
TABLE 24 SINGLE-CELL ANALYSIS ASSAY KITS MARKET, BY REGION, 2021-2028 (USD MILLION)
TABLE 25 SINGLE-CELL ANALYSIS ASSAY KITS MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
6.2.4.1 Immunoassays
6.2.4.1.1 Innovations in immunoassays to drive growth
TABLE 26 SINGLE-CELL ANALYSIS IMMUNOASSAYS MARKET, BY REGION, 2021-2028 (USD MILLION)
TABLE 27 SINGLE-CELL ANALYSIS IMMUNOASSAYS MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
6.2.4.2 Cell-based assays
6.2.4.2.1 Rising R&D activities in pharma and biopharma companies to drive demand
TABLE 28 SINGLE-CELL ANALYSIS CELL-BASED ASSAYS MARKET, BY REGION, 2021-2028 (USD MILLION)
TABLE 29 SINGLE-CELL ANALYSIS CELL-BASED ASSAYS MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
6.2.5 OTHER CONSUMABLES
TABLE 30 ANALYSIS MARKET FOR OTHER CONSUMABLES, BY REGION, 2021-2028 (USD MILLION)
TABLE 31 ANALYSIS MARKET FOR OTHER CONSUMABLES, BY COUNTRY, 2021-2028 (USD MILLION)
6.3 INSTRUMENTS
TABLE 32 SINGLE-CELL ANALYSIS INSTRUMENTS MARKET, BY TYPE, 2021-2028 (USD MILLION)
TABLE 33 SINGLE-CELL ANALYSIS INSTRUMENTS MARKET, BY REGION, 2021-2028 (USD MILLION)
TABLE 34 SINGLE-CELL ANALYSIS INSTRUMENTS MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
6.3.1 FLOW CYTOMETERS
6.3.1.1 Technological advancements in flow cytometry to drive market
TABLE 35 SINGLE-CELL ANALYSIS FLOW CYTOMETERS MARKET, BY REGION, 2021-2028 (USD MILLION)
TABLE 36 SINGLE-CELL ANALYSIS FLOW CYTOMETERS MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
6.3.2 NGS SYSTEMS
6.3.2.1 Advancements in NGS systems to support market growth
TABLE 37 SINGLE-CELL ANALYSIS NGS SYSTEMS MARKET, BY REGION, 2021-2028 (USD MILLION)
TABLE 38 SINGLE-CELL ANALYSIS NGS SYSTEMS MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
6.3.3 PCR INSTRUMENTS
6.3.3.1 Use of PCR to amplify DNA and mRNA from single cells to study gene expression to boost market growth
TABLE 39 SINGLE-CELL ANALYSIS PCR INSTRUMENTS MARKET, BY REGION, 2021-2028 (USD MILLION)
TABLE 40 SINGLE-CELL ANALYSIS PCR INSTRUMENTS MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
6.3.4 SPECTROPHOTOMETERS
6.3.4.1 Significant technological advancements to favor market growth
TABLE 41 SINGLE-CELL ANALYSIS SPECTROPHOTOMETERS MARKET, BY REGION, 2021-2028 (USD MILLION)
TABLE 42 SINGLE-CELL ANALYSIS SPECTROPHOTOMETERS MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
6.3.5 CELL COUNTERS
6.3.5.1 Reliable and quick results to support adoption
TABLE 43 SINGLE-CELL ANALYSIS CELL COUNTERS MARKET, BY REGION, 2021-2028 (USD MILLION)
TABLE 44 SINGLE-CELL ANALYSIS CELL COUNTERS MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
6.3.6 MICROSCOPES
6.3.6.1 Wide applications in cell-based research to drive adoption
TABLE 45 SINGLE-CELL ANALYSIS MICROSCOPES MARKET, BY REGION, 2021-2028 (USD MILLION)
TABLE 46 SINGLE-CELL ANALYSIS MICROSCOPES MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
6.3.7 HCS SYSTEMS
6.3.7.1 Increasing need for multi-parametric cell analysis to drive adoption
TABLE 47 SINGLE-CELL ANALYSIS HCS SYSTEMS MARKET, BY REGION, 2021-2028 (USD MILLION)
TABLE 48 SINGLE-CELL ANALYSIS HCS SYSTEMS MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
6.3.8 MICROARRAYS
6.3.8.1 Increasing demand in molecular biology to support market growth
TABLE 49 SINGLE-CELL ANALYSIS MICROARRAYS MARKET, BY REGION, 2021-2028 (USD MILLION)
TABLE 50 SINGLE-CELL ANALYSIS MICROARRAYS MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
6.3.9 OTHER INSTRUMENTS
TABLE 51 MARKET FOR OTHER INSTRUMENTS, BY REGION, 2021-2028 (USD MILLION)
TABLE 52 MARKET FOR OTHER INSTRUMENTS, BY COUNTRY, 2021-2028 (USD MILLION)

7 SINGLE CELL ANALYSIS MARKET, BY CELL TYPE (Page No. - 116)
7.1 INTRODUCTION
TABLE 53 SINGLE CELL ANALYSIS INDUSTRY, BY CELL TYPE, 2021-2028 (USD MILLION)
7.2 HUMAN CELLS
7.2.1 INCREASING CANCER RESEARCH & FUNDING TO PROPEL MARKET
TABLE 54 MARKET FOR HUMAN CELLS, BY REGION, 2021-2028 (USD MILLION)
TABLE 55 MARKET FOR HUMAN CELLS, BY COUNTRY, 2021-2028 (USD MILLION)
7.3 ANIMAL CELLS
7.3.1 INCREASING ANIMAL CELL RESEARCH TO DRIVE MARKET
TABLE 56 MARKET FOR ANIMAL CELLS, BY REGION, 2021-2028 (USD MILLION)
TABLE 57 MARKET FOR ANIMAL CELLS, BY COUNTRY, 2021-2028 (USD MILLION)
7.4 MICROBIAL CELLS
7.4.1 RISING GOVERNMENT SUPPORT TO DETECT AND COMBAT ANTIMICROBIAL RESISTANCE TO PROPEL MARKET
TABLE 58 MARKET FOR MICROBIAL CELLS, BY REGION, 2021-2028 (USD MILLION)
TABLE 59 MARKET FOR MICROBIAL CELLS, BY COUNTRY, 2021-2028 (USD MILLION)

8 SINGLE CELL ANALYSIS MARKET, BY TECHNIQUE (Page No. - 123)
8.1 INTRODUCTION
TABLE 60 SINGLE CELL ANALYSIS INDUSTRY, BY TECHNIQUE, 2021-2028 (USD MILLION)
8.2 FLOW CYTOMETRY
8.2.1 WIDE USAGE TO STUDY CELL MORPHOLOGIES AND IDENTIFY CANCEROUS CELLS TO DRIVE MARKET
TABLE 61 MARKET FOR FLOW CYTOMETRY, BY REGION, 2021-2028 (USD MILLION)
TABLE 62 MARKET FOR FLOW CYTOMETRY, BY COUNTRY, 2021-2028 (USD MILLION)
8.3 NEXT-GENERATION SEQUENCING
8.3.1 ADVANTAGES SUCH AS EFFECTIVE SCREENING AND MANAGEMENT OF HIGH-VOLUME DATA TO BOOST ADOPTION
TABLE 63 MARKET FOR NEXT-GENERATION SEQUENCING, BY REGION, 2021-2028 (USD MILLION)
TABLE 64 MARKET FOR NEXT-GENERATION SEQUENCING, BY COUNTRY, 2021-2028 (USD MILLION)
8.4 POLYMERASE CHAIN REACTION
8.4.1 ADVANCEMENTS IN PCR TECHNIQUES TO SUPPORT MARKET GROWTH
TABLE 65 MARKET FOR POLYMERASE CHAIN REACTION, BY REGION, 2021-2028 (USD MILLION)
TABLE 66 MARKET FOR POLYMERASE CHAIN REACTION, BY COUNTRY, 2021-2028 (USD MILLION)
8.5 MICROSCOPY
8.5.1 INCREASING INVESTMENTS IN CELL BIOLOGY RESEARCH TO PROPEL MARKET
TABLE 67 MARKET FOR MICROSCOPY, BY REGION, 2021-2028 (USD MILLION)
TABLE 68 MARKET FOR MICROSCOPY, BY COUNTRY, 2021-2028 (USD MILLION)
8.6 MASS SPECTROMETRY
8.6.1 LAUNCH OF NEW AND ADVANCED PRODUCTS TO SUPPORT MARKET GROWTH
TABLE 69 MARKET FOR MASS SPECTROMETRY, BY REGION, 2021-2028 (USD MILLION)
TABLE 70 MARKET FOR MASS SPECTROMETRY, BY COUNTRY, 2021-2028 (USD MILLION)
8.7 OTHER TECHNIQUES
TABLE 71 MARKET FOR OTHER TECHNIQUES, BY REGION, 2021-2028 (USD MILLION)
TABLE 72 MARKET FOR OTHER TECHNIQUES, BY COUNTRY, 2021-2028 (USD MILLION)

9 SINGLE CELL ANALYSIS MARKET, BY APPLICATION (Page No. - 134)
9.1 INTRODUCTION
TABLE 73 SINGLE CELL ANALYSIS INDUSTRY, BY APPLICATION, 2021-2028 (USD MILLION)
9.2 RESEARCH APPLICATIONS
TABLE 74 SINGLE CELL-ANALYSIS MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2021-2028 (USD MILLION)
TABLE 75 SINGLE CELL-ANALYSIS MARKET FOR RESEARCH APPLICATIONS, BY REGION, 2021-2028 (USD MILLION)
TABLE 76 MARKET FOR RESEARCH APPLICATIONS, BY COUNTRY, 2021-2028 (USD MILLION)
9.2.1 CANCER RESEARCH
9.2.1.1 Growing prevalence of cancer to support market growth
TABLE 77 MARKET FOR CANCER RESEARCH, BY REGION, 2021-2028 (USD MILLION)
TABLE 78 MARKET FOR CANCER RESEARCH, BY COUNTRY, 2021-2028 (USD MILLION)
9.2.2 IMMUNOLOGY RESEARCH
9.2.2.1 High incidence of infectious diseases and growing demand for advanced vaccines to propel market
TABLE 79 MARKET FOR IMMUNOLOGY RESEARCH, BY REGION, 2021-2028 (USD MILLION)
TABLE 80 MARKET FOR IMMUNOLOGY RESEARCH, BY COUNTRY, 2021-2028 (USD MILLION)
9.2.3 NEUROLOGY RESEARCH
9.2.3.1 Increasing incidence of neurological disorders to propel market
TABLE 81 MARKET FOR NEUROLOGY RESEARCH, BY REGION, 2021-2028 (USD MILLION)
TABLE 82 MARKET FOR NEUROLOGY RESEARCH, BY COUNTRY, 2021-2028 (USD MILLION)
9.2.4 STEM CELL RESEARCH
9.2.4.1 Rising investments in stem cell research to drive market
TABLE 83 MARKET FOR STEM CELL RESEARCH, BY REGION, 2021-2028 (USD MILLION)
TABLE 84 MARKET FOR STEM CELL RESEARCH, BY COUNTRY, 2021-2028 (USD MILLION)
9.2.5 OTHER RESEARCH APPLICATIONS
TABLE 85 MARKET FOR OTHER RESEARCH APPLICATIONS, BY REGION, 2021-2028 (USD MILLION)
TABLE 86 MARKET FOR OTHER RESEARCH APPLICATIONS, BY COUNTRY, 2021-2028 (USD MILLION)
9.3 MEDICAL APPLICATIONS
TABLE 87 MARKET FOR MEDICAL APPLICATIONS, BY TYPE, 2021-2028 (USD MILLION)
TABLE 88 MARKET FOR MEDICAL APPLICATIONS, BY REGION, 2021-2028 (USD MILLION)
TABLE 89 MARKET FOR MEDICAL APPLICATIONS, BY COUNTRY, 2021-2028 (USD MILLION)
9.3.1 NONINVASIVE PRENATAL DIAGNOSIS
9.3.1.1 Rising prevalence of genetic diseases to drive market
TABLE 90 MARKET FOR NONINVASIVE PRENATAL DIAGNOSIS, BY REGION, 2021-2028 (USD MILLION)
TABLE 91 MARKET FOR NON INVASIVE PRENATAL DIAGNOSIS, BY COUNTRY, 2021-2028 (USD MILLION)
9.3.2 IN VITRO FERTILIZATION
9.3.2.1 Increasing demand for IVF procedures to support market growth
TABLE 92 MARKET FOR IN VITRO FERTILIZATION, BY REGION, 2021-2028 (USD MILLION)
TABLE 93 MARKET FOR IN VITRO FERTILIZATION, BY COUNTRY, 2021-2028 (USD MILLION)
9.3.3 CIRCULATING TUMOR CELL DETECTION
9.3.3.1 Rising prevalence of cancer to drive market
TABLE 94 MARKET FOR CIRCULATING TUMOR CELL DETECTION, BY REGION, 2021-2028 (USD MILLION)
TABLE 95 MARKET FOR CIRCULATING TUMOUR CELL DETECTION, BY COUNTRY, 2021-2028 (USD MILLION)

10 SINGLE CELL ANALYSIS MARKET, BY END USER (Page No. - 152)
10.1 INTRODUCTION
TABLE 96 SINGLE CELL ANALYSIS INDUSTRY, BY END USER, 2021-2028 (USD MILLION)
10.2 ACADEMIC & RESEARCH LABORATORIES
10.2.1 INCREASING FUNDING FOR LIFE SCIENCE RESEARCH TO DRIVE MARKET
TABLE 97 MARKET FOR ACADEMIC & RESEARCH LABORATORIES, BY REGION, 2021-2028 (USD MILLION)
TABLE 98 MARKET FOR ACADEMIC & RESEARCH LABORATORIES, BY COUNTRY, 2021-2028 (USD MILLION)
10.3 BIOTECHNOLOGY & PHARMACEUTICAL COMPANIES
10.3.1 GROWTH IN DRUG DISCOVERY AND R&D ACTIVITIES TO SUPPORT MARKET GROWTH
TABLE 99 MARKET FOR BIOTECHNOLOGY & PHARMACEUTICAL COMPANIES, BY REGION, 2021-2028 (USD MILLION)
TABLE 100 MARKET FOR BIOTECHNOLOGY & PHARMACEUTICAL COMPANIES, BY COUNTRY, 2021-2028 (USD MILLION)
10.4 HOSPITALS & DIAGNOSTIC LABORATORIES
10.4.1 HIGH PREVALENCE OF INFECTIOUS & CHRONIC DISEASES TO DRIVE ADOPTION
TABLE 101 MARKET FOR HOSPITALS & DIAGNOSTIC LABORATORIES, BY REGION, 2021-2028 (USD MILLION)
TABLE 102 MARKET FOR HOSPITALS & DIAGNOSTIC LABORATORIES, BY COUNTRY, 2021-2028 (USD MILLION)
10.5 CELL BANKS & IVF CENTERS
10.5.1 RISING DEMAND FOR PERSONALIZED & REGENERATIVE MEDICINE TO SUPPORT MARKET GROWTH
TABLE 103 MARKET FOR CELL BANKS & IVF CENTERS, BY REGION, 2021-2028 (USD MILLION)
TABLE 104 MARKET FOR CELL BANKS & IVF CENTERS, BY COUNTRY, 2021-2028 (USD MILLION)

11 SINGLE CELL ANALYSIS MARKET, BY REGION (Page No. - 161)
11.1 INTRODUCTION
TABLE 105 SINGLE CELL ANALYSIS INDUSTRY, BY REGION, 2021-2028 (USD MILLION)
11.2 NORTH AMERICA
FIGURE 30 NORTH AMERICA: SINGLE CELL ANALYSIS MARKET SNAPSHOT
TABLE 106 NORTH AMERICA: MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
TABLE 107 NORTH AMERICA: MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
TABLE 108 NORTH AMERICA: SINGLE-CELL ANALYSIS CONSUMABLES MARKET, BY TYPE, 2021-2028 (USD MILLION)
TABLE 109 NORTH AMERICA: SINGLE-CELL ANALYSIS ASSAY KITS MARKET, BY TYPE, 2021-2028 (USD MILLION)
TABLE 110 NORTH AMERICA: SINGLE-CELL ANALYSIS INSTRUMENTS MARKET, BY TYPE, 2021-2028 (USD MILLION)
TABLE 111 NORTH AMERICA: MARKET, BY CELL TYPE, 2021-2028 (USD MILLION)
TABLE 112 NORTH AMERICA: MARKET, BY TECHNIQUE, 2021-2028 (USD MILLION)
TABLE 113 NORTH AMERICA: MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
TABLE 114 NORTH AMERICA: MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2021-2028 (USD MILLION)
TABLE 115 NORTH AMERICA: MARKET FOR MEDICAL APPLICATIONS, BY TYPE, 2021-2028 (USD MILLION)
TABLE 116 NORTH AMERICA: MARKET, BY END USER, 2021-2028 (USD MILLION)
11.2.1 US
11.2.1.1 Increasing R&D investments and funding to drive market
FIGURE 31 NIH FUNDING FOR STEM CELL RESEARCH (2011-2021)
TABLE 117 US: SINGLE CELL ANALYSIS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
TABLE 118 US: SINGLE-CELL ANALYSIS CONSUMABLES MARKET, BY TYPE, 2021-2028 (USD MILLION)
TABLE 119 US: SINGLE-CELL ANALYSIS ASSAY KITS MARKET, BY TYPE, 2021-2028 (USD MILLION)
TABLE 120 US: SINGLE-CELL ANALYSIS INSTRUMENTS MARKET, BY TYPE, 2021-2028 (USD MILLION)
TABLE 121 US: MARKET, BY CELL TYPE, 2021-2028 (USD MILLION)
TABLE 122 US: MARKET, BY TECHNIQUE, 2021-2028 (USD MILLION)
TABLE 123 US: MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
TABLE 124 US: MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2021-2028 (USD MILLION)
TABLE 125 US: MARKET FOR MEDICAL APPLICATIONS, BY TYPE, 2021-2028 (USD MILLION)
TABLE 126 US: SINGLE CELL ANALYSIS INDUSTRY, BY END USER, 2021-2028 (USD MILLION)
11.2.2 CANADA
11.2.2.1 High prevalence of hemophilia to drive market
TABLE 127 CANADA: SINGLE CELL ANALYSIS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
TABLE 128 CANADA: SINGLE-CELL ANALYSIS CONSUMABLES MARKET, BY TYPE, 2021-2028 (USD MILLION)
TABLE 129 CANADA: SINGLE-CELL ANALYSIS ASSAY KITS MARKET, BY TYPE, 2021-2028 (USD MILLION)
TABLE 130 CANADA: SINGLE-CELL ANALYSIS INSTRUMENTS MARKET, BY TYPE, 2021-2028 (USD MILLION)
TABLE 131 CANADA: MARKET, BY CELL TYPE, 2021-2028 (USD MILLION)
TABLE 132 CANADA: MARKET, BY TECHNIQUE, 2021-2028 (USD MILLION)
TABLE 133 CANADA: MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
TABLE 134 CANADA: MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2021-2028 (USD MILLION)
TABLE 135 CANADA: MARKET FOR MEDICAL APPLICATIONS, BY TYPE, 2021-2028 (USD MILLION)
TABLE 136 CANADA: MARKET, BY END USER, 2021-2028 (USD MILLION)
11.2.3 NORTH AMERICA: RECESSION IMPACT
11.3 EUROPE
TABLE 137 EUROPE: SINGLE CELL ANALYSIS MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
TABLE 138 EUROPE: MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
TABLE 139 EUROPE: SINGLE-CELL ANALYSIS CONSUMABLES MARKET, BY TYPE, 2021-2028 (USD MILLION)
TABLE 140 EUROPE: SINGLE-CELL ANALYSIS ASSAY KITS MARKET, BY TYPE, 2021-2028 (USD MILLION)
TABLE 141 EUROPE: SINGLE-CELL ANALYSIS INSTRUMENTS MARKET, BY TYPE, 2021-2028 (USD MILLION)
TABLE 142 EUROPE: MARKET, BY CELL TYPE, 2021-2028 (USD MILLION)
TABLE 143 EUROPE: MARKET, BY TECHNIQUE, 2021-2028 (USD MILLION)
TABLE 144 EUROPE: MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
TABLE 145 EUROPE: MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2021-2028 (USD MILLION)
TABLE 146 EUROPE: MARKET FOR MEDICAL APPLICATIONS, BY TYPE, 2021-2028 (USD MILLION)
TABLE 147 EUROPE: SINGLE CELL ANALYSIS INDUSTRY, BY END USER, 2021-2028 (USD MILLION)
11.3.1 GERMANY
11.3.1.1 Government support for research funding to propel market
TABLE 148 GERMANY: SINGLE CELL ANALYSIS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
TABLE 149 GERMANY: SINGLE-CELL ANALYSIS CONSUMABLES MARKET, BY TYPE, 2021-2028 (USD MILLION)
TABLE 150 GERMANY: SINGLE-CELL ANALYSIS ASSAY KITS MARKET, BY TYPE, 2021-2028 (USD MILLION)
TABLE 151 GERMANY: SINGLE-CELL ANALYSIS INSTRUMENTS MARKET, BY TYPE, 2021-2028 (USD MILLION)
TABLE 152 GERMANY: MARKET, BY CELL TYPE, 2021-2028 (USD MILLION)
TABLE 153 GERMANY: MARKET, BY TECHNIQUE, 2021-2028 (USD MILLION)
TABLE 154 GERMANY: MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
TABLE 155 GERMANY: MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2021-2028 (USD MILLION)
TABLE 156 GERMANY: MARKET FOR MEDICAL APPLICATIONS, BY TYPE, 2021-2028 (USD MILLION)
TABLE 157 GERMANY: MARKET, BY END USER, 2021-2028 (USD MILLION)
11.3.2 UK
11.3.2.1 Favorable research conditions to support market growth
TABLE 158 UK: SINGLE CELL ANALYSIS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
TABLE 159 UK: SINGLE-CELL ANALYSIS CONSUMABLES MARKET, BY TYPE, 2021-2028 (USD MILLION)
TABLE 160 UK: SINGLE-CELL ANALYSIS ASSAY KITS MARKET, BY TYPE, 2021-2028 (USD MILLION)
TABLE 161 UK: SINGLE-CELL ANALYSIS INSTRUMENTS MARKET, BY TYPE, 2021-2028 (USD MILLION)
TABLE 162 UK: MARKET, BY CELL TYPE, 2021-2028 (USD MILLION)
TABLE 163 UK: MARKET, BY TECHNIQUE, 2021-2028 (USD MILLION)
TABLE 164 UK: MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
TABLE 165 UK: MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2021-2028 (USD MILLION)
TABLE 166 UK: MARKET FOR MEDICAL APPLICATIONS, BY TYPE, 2021-2028 (USD MILLION)
TABLE 167 UK: SINGLE CELL ANALYSIS INDUSTRY, BY END USER, 2021-2028 (USD MILLION)
11.3.3 FRANCE
11.3.3.1 High burden of cancer to propel market
TABLE 168 FRANCE: SINGLE CELL ANALYSIS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
TABLE 169 FRANCE: SINGLE-CELL ANALYSIS CONSUMABLES MARKET, BY TYPE, 2021-2028 (USD MILLION)
TABLE 170 FRANCE: SINGLE-CELL ANALYSIS ASSAY KITS MARKET, BY TYPE, 2021-2028 (USD MILLION)
TABLE 171 FRANCE: SINGLE-CELL ANALYSIS INSTRUMENTS MARKET, BY TYPE, 2021-2028 (USD MILLION)
TABLE 172 FRANCE: MARKET, BY CELL TYPE, 2021-2028 (USD MILLION)
TABLE 173 FRANCE: MARKET, BY TECHNIQUE, 2021-2028 (USD MILLION)
TABLE 174 FRANCE: MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
TABLE 175 FRANCE: MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2021-2028 (USD MILLION)
TABLE 176 FRANCE: MARKET FOR MEDICAL APPLICATIONS, BY TYPE, 2021-2028 (USD MILLION)
TABLE 177 FRANCE: MARKET, BY END USER, 2021-2028 (USD MILLION)
11.3.4 ITALY
11.3.4.1 Increasing cell biology seminars and conferences to drive market
TABLE 178 ITALY: SINGLE CELL ANALYSIS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
TABLE 179 ITALY: SINGLE-CELL ANALYSIS CONSUMABLES MARKET, BY TYPE, 2021-2028 (USD MILLION)
TABLE 180 ITALY: SINGLE-CELL ANALYSIS ASSAY KITS MARKET, BY TYPE, 2021-2028 (USD MILLION)
TABLE 181 ITALY: SINGLE-CELL ANALYSIS INSTRUMENTS MARKET, BY TYPE, 2021-2028 (USD MILLION)
TABLE 182 ITALY: MARKET, BY CELL TYPE, 2021-2028 (USD MILLION)
TABLE 183 ITALY: MARKET, BY TECHNIQUE, 2021-2028 (USD MILLION)
TABLE 184 ITALY: MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
TABLE 185 ITALY: MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2021-2028 (USD MILLION)
TABLE 186 ITALY: MARKET FOR MEDICAL APPLICATIONS, BY TYPE, 2021-2028 (USD MILLION)
TABLE 187 ITALY: MARKET, BY END USER, 2021-2028 (USD MILLION)
11.3.5 SPAIN
11.3.5.1 Strong R&D infrastructure and growing focus on cancer research to drive market
TABLE 188 SPAIN: SINGLE CELL ANALYSIS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
TABLE 189 SPAIN: SINGLE-CELL ANALYSIS CONSUMABLES MARKET, BY TYPE, 2021-2028 (USD MILLION)
TABLE 190 SPAIN: SINGLE-CELL ANALYSIS ASSAY KITS MARKET, BY TYPE, 2021-2028 (USD MILLION)
TABLE 191 SPAIN: SINGLE-CELL ANALYSIS INSTRUMENTS MARKET, BY TYPE, 2021-2028 (USD MILLION)
TABLE 192 SPAIN: MARKET, BY CELL TYPE, 2021-2028 (USD MILLION)
TABLE 193 SPAIN: MARKET, BY TECHNIQUE, 2021-2028 (USD MILLION)
TABLE 194 SPAIN: MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
TABLE 195 SPAIN: MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2021-2028 (USD MILLION)
TABLE 196 SPAIN: MARKET FOR MEDICAL APPLICATIONS, BY TYPE, 2021-2028 (USD MILLION)
TABLE 197 SPAIN: SINGLE CELL ANALYSIS INDUSTRY, BY END USER, 2021-2028 (USD MILLION)
11.3.6 REST OF EUROPE
TABLE 198 REST OF EUROPE: SINGLE CELL ANALYSIS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
TABLE 199 REST OF EUROPE: SINGLE-CELL ANALYSIS CONSUMABLES MARKET, BY TYPE, 2021-2028 (USD MILLION)
TABLE 200 REST OF EUROPE: SINGLE-CELL ANALYSIS ASSAY KITS MARKET, BY TYPE, 2021-2028 (USD MILLION)
TABLE 201 REST OF EUROPE: SINGLE-CELL ANALYSIS INSTRUMENTS MARKET, BY TYPE, 2021-2028 (USD MILLION)
TABLE 202 REST OF EUROPE: MARKET, BY CELL TYPE, 2021-2028 (USD MILLION)
TABLE 203 REST OF EUROPE: MARKET, BY TECHNIQUE, 2021-2028 (USD MILLION)
TABLE 204 REST OF EUROPE: MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
TABLE 205 REST OF EUROPE: MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2021-2028 (USD MILLION)
TABLE 206 REST OF EUROPE: MARKET FOR MEDICAL APPLICATIONS, BY TYPE, 2021-2028 (USD MILLION)
TABLE 207 REST OF EUROPE: MARKET, BY END USER, 2021-2028 (USD MILLION)
11.3.7 EUROPE: RECESSION IMPACT
11.4 ASIA PACIFIC
FIGURE 32 ASIA PACIFIC: SINGLE CELL ANALYSIS MARKET SNAPSHOT
TABLE 208 ASIA PACIFIC: MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
TABLE 209 ASIA PACIFIC: MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
TABLE 210 ASIA PACIFIC: SINGLE-CELL ANALYSIS CONSUMABLES MARKET, BY TYPE, 2021-2028 (USD MILLION)
TABLE 211 ASIA PACIFIC: SINGLE-CELL ANALYSIS ASSAY KITS MARKET, BY TYPE, 2021-2028 (USD MILLION)
TABLE 212 ASIA PACIFIC: SINGLE-CELL ANALYSIS INSTRUMENTS MARKET, BY TYPE, 2021-2028 (USD MILLION)
TABLE 213 ASIA PACIFIC: MARKET, BY CELL TYPE, 2021-2028 (USD MILLION)
TABLE 214 ASIA PACIFIC: MARKET, BY TECHNIQUE, 2021-2028 (USD MILLION)
TABLE 215 ASIA PACIFIC: MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
TABLE 216 ASIA PACIFIC: MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2021-2028 (USD MILLION)
TABLE 217 ASIA PACIFIC: MARKET FOR MEDICAL APPLICATIONS, BY TYPE, 2021-2028 (USD MILLION)
TABLE 218 ASIA PACIFIC: MARKET, BY END USER, 2021-2028 (USD MILLION)
11.4.1 CHINA
11.4.1.1 Government initiatives to promote stem cell research to propel market
TABLE 219 CHINA: SINGLE CELL ANALYSIS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
TABLE 220 CHINA: SINGLE-CELL ANALYSIS CONSUMABLES MARKET, BY TYPE, 2021-2028 (USD MILLION)
TABLE 221 CHINA: SINGLE-CELL ANALYSIS ASSAY KITS MARKET, BY TYPE, 2021-2028 (USD MILLION)
TABLE 222 CHINA: SINGLE-CELL ANALYSIS INSTRUMENTS MARKET, BY TYPE, 2021-2028 (USD MILLION)
TABLE 223 CHINA: MARKET, BY CELL TYPE, 2021-2028 (USD MILLION)
TABLE 224 CHINA: MARKET, BY TECHNIQUE, 2021-2028 (USD MILLION)
TABLE 225 CHINA: MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
TABLE 226 CHINA: MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2021-2028 (USD MILLION)
TABLE 227 CHINA: MARKET FOR MEDICAL APPLICATIONS, BY TYPE, 2021-2028 (USD MILLION)
TABLE 228 CHINA: SINGLE CELL ANALYSIS INDUSTRY, BY END USER, 2021-2028 (USD MILLION)
11.4.2 JAPAN
11.4.2.1 Rising geriatric population and growing focus on personalized medicine to drive market
TABLE 229 JAPAN: CANCER INCIDENCE, BY TYPE, 2018 VS. 2025
TABLE 230 JAPAN: SINGLE CELL ANALYSIS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
TABLE 231 JAPAN: SINGLE-CELL ANALYSIS CONSUMABLES MARKET, BY TYPE, 2021-2028 (USD MILLION)
TABLE 232 JAPAN: SINGLE-CELL ANALYSIS ASSAY KITS MARKET, BY TYPE, 2021-2028 (USD MILLION)
TABLE 233 JAPAN: SINGLE-CELL ANALYSIS INSTRUMENTS MARKET, BY TYPE, 2021-2028 (USD MILLION)
TABLE 234 JAPAN: MARKET, BY CELL TYPE, 2021-2028 (USD MILLION)
TABLE 235 JAPAN: MARKET, BY TECHNIQUE, 2021-2028 (USD MILLION)
TABLE 236 JAPAN: MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
TABLE 237 JAPAN: MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2021-2028 (USD MILLION)
TABLE 238 JAPAN: MARKET FOR MEDICAL APPLICATIONS, BY TYPE, 2021-2028 (USD MILLION)
TABLE 239 JAPAN: MARKET, BY END USER, 2021-2028 (USD MILLION)
11.4.3 INDIA
11.4.3.1 Expansion of pharmaceutical and biotechnology industries to support market growth
TABLE 240 INDIA: SINGLE CELL ANALYSIS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
TABLE 241 INDIA: SINGLE-CELL ANALYSIS CONSUMABLES MARKET, BY TYPE, 2021-2028 (USD MILLION)
TABLE 242 INDIA: SINGLE-CELL ANALYSIS ASSAY KITS MARKET, BY TYPE, 2021-2028 (USD MILLION)
TABLE 243 INDIA: SINGLE-CELL ANALYSIS INSTRUMENTS MARKET, BY TYPE, 2021-2028 (USD MILLION)
TABLE 244 INDIA: MARKET, BY CELL TYPE, 2021-2028 (USD MILLION)
TABLE 245 INDIA: MARKET, BY TECHNIQUE, 2021-2028 (USD MILLION)
TABLE 246 INDIA: MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
TABLE 247 INDIA: MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2021-2028 (USD MILLION)
TABLE 248 INDIA: MARKET FOR MEDICAL APPLICATIONS, BY TYPE, 2021-2028 (USD MILLION)
TABLE 249 INDIA: MARKET, BY END USER, 2021-2028 (USD MILLION)
11.4.4 REST OF ASIA PACIFIC
TABLE 250 REST OF ASIA PACIFIC: SINGLE CELL ANALYSIS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
TABLE 251 REST OF ASIA PACIFIC: SINGLE-CELL ANALYSIS CONSUMABLES MARKET, BY TYPE, 2021-2028 (USD MILLION)
TABLE 252 REST OF ASIA PACIFIC: SINGLE-CELL ANALYSIS ASSAY KITS MARKET, BY TYPE, 2021-2028 (USD MILLION)
TABLE 253 REST OF ASIA PACIFIC: SINGLE-CELL ANALYSIS INSTRUMENTS MARKET, BY TYPE, 2021-2028 (USD MILLION)
TABLE 254 REST OF ASIA PACIFIC: MARKET, BY CELL TYPE, 2021-2028 (USD MILLION)
TABLE 255 REST OF ASIA PACIFIC: MARKET, BY TECHNIQUE, 2021-2028 (USD MILLION)
TABLE 256 REST OF ASIA PACIFIC: MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
TABLE 257 REST OF ASIA PACIFIC: MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2021-2028 (USD MILLION)
TABLE 258 REST OF ASIA PACIFIC: MARKET FOR MEDICAL APPLICATIONS, BY TYPE, 2021-2028 (USD MILLION)
TABLE 259 REST OF ASIA PACIFIC: SINGLE CELL ANALYSIS INDUSTRY, BY END USER, 2021-2028 (USD MILLION)
11.4.5 ASIA PACIFIC: RECESSION IMPACT
11.5 LATIN AMERICA
11.5.1 EXPANSION OF BIOTECHNOLOGY AND PHARMACEUTICAL INDUSTRIES TO DRIVE MARKET
11.5.2 LATIN AMERICA: RECESSION IMPACT
TABLE 260 LATIN AMERICA: SINGLE CELL ANALYSIS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
TABLE 261 LATIN AMERICA: SINGLE-CELL ANALYSIS CONSUMABLES MARKET, BY TYPE, 2021-2028 (USD MILLION)
TABLE 262 LATIN AMERICA: SINGLE-CELL ANALYSIS ASSAY KITS MARKET, BY TYPE, 2021-2028 (USD MILLION)
TABLE 263 LATIN AMERICA: SINGLE-CELL ANALYSIS INSTRUMENTS MARKET, BY TYPE, 2021-2028 (USD MILLION)
TABLE 264 LATIN AMERICA: MARKET, BY CELL TYPE, 2021-2028 (USD MILLION)
TABLE 265 LATIN AMERICA: MARKET, BY TECHNIQUE, 2021-2028 (USD MILLION)
TABLE 266 LATIN AMERICA: MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
TABLE 267 LATIN AMERICA: MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2021-2028 (USD MILLION)
TABLE 268 LATIN AMERICA: MARKET FOR MEDICAL APPLICATIONS, BY TYPE, 2021-2028 (USD MILLION)
TABLE 269 LATIN AMERICA: MARKET, BY END USER, 2021-2028 (USD MILLION)
11.6 MIDDLE EAST & AFRICA
11.6.1 RISING PREVALENCE OF CHRONIC AND INFECTIOUS DISEASES TO DRIVE MARKET
11.6.2 MIDDLE EAST & AFRICA: RECESSION IMPACT
TABLE 270 MIDDLE EAST & AFRICA: SINGLE CELL ANALYSIS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
TABLE 271 MIDDLE EAST & AFRICA: SINGLE-CELL ANALYSIS CONSUMABLES MARKET, BY TYPE, 2021-2028 (USD MILLION)
TABLE 272 MIDDLE EAST & AFRICA: SINGLE-CELL ANALYSIS ASSAY KITS MARKET, BY TYPE, 2021-2028 (USD MILLION)
TABLE 273 MIDDLE EAST & AFRICA: SINGLE-CELL ANALYSIS INSTRUMENTS MARKET, BY TYPE, 2021-2028 (USD MILLION)
TABLE 274 MIDDLE EAST & AFRICA: MARKET, BY CELL TYPE, 2021-2028 (USD MILLION)
TABLE 275 MIDDLE EAST & AFRICA: MARKET, BY TECHNIQUE, 2021-2028 (USD MILLION)
TABLE 276 MIDDLE EAST & AFRICA: MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
TABLE 277 MIDDLE EAST & AFRICA: MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2021-2028 (USD MILLION)
TABLE 278 MIDDLE EAST & AFRICA: MARKET FOR MEDICAL APPLICATIONS, BY TYPE, 2021-2028 (USD MILLION)
TABLE 279 MIDDLE EAST & AFRICA: MARKET, BY END USER, 2021-2028 (USD MILLION)

12 COMPETITIVE LANDSCAPE (Page No. - 254)
12.1 INTRODUCTION
12.2 KEY STRATEGIES ADOPTED BY MARKET PLAYERS
FIGURE 33 SINGLE CELL ANALYSIS MARKET: STRATEGIES ADOPTED
12.3 REVENUE ANALYSIS
FIGURE 34 REVENUE ANALYSIS FOR KEY COMPANIES, 2020-2022
12.4 MARKET SHARE ANALYSIS
FIGURE 35 SINGLE CELL ANALYSIS INDUSTRY SHARE, BY KEY PLAYER (2022)
TABLE 280 SINGLE CELL ANALYSIS INDUSTRY: DEGREE OF COMPETITION
12.5 COMPANY EVALUATION QUADRANT FOR KEY PLAYERS
12.5.1 STARS
12.5.2 EMERGING LEADERS
12.5.3 PERVASIVE PLAYERS
12.5.4 PARTICIPANTS
FIGURE 36 MARKET: COMPETITIVE LEADERSHIP MAPPING FOR KEY PLAYERS, 2022
12.6 COMPANY EVALUATION QUADRANT FOR STARTUPS/SMES
12.6.1 PROGRESSIVE COMPANIES
12.6.2 STARTING BLOCKS
12.6.3 RESPONSIVE COMPANIES
12.6.4 DYNAMIC COMPANIES
FIGURE 37 MARKET: COMPANY EVALUATION MATRIX FOR STARTUPS/SMES, 2022
12.7 COMPETITIVE BENCHMARKING
12.7.1 COMPANY FOOTPRINT ANALYSIS (25 COMPANIES)
TABLE 281 PRODUCT AND REGIONAL FOOTPRINT ANALYSIS OF KEY PLAYERS
12.7.2 PRODUCT FOOTPRINT ANALYSIS OF COMPANIES (25 COMPANIES)
TABLE 282 PRODUCT FOOTPRINT ANALYSIS OF KEY PLAYERS IN MARKET
12.7.3 REGIONAL FOOTPRINT ANALYSIS OF COMPANIES (25 COMPANIES)
TABLE 283 REGIONAL FOOTPRINT ANALYSIS OF KEY PLAYERS IN MARKET
12.8 COMPETITIVE SCENARIO AND TRENDS
12.8.1 PRODUCT LAUNCHES
TABLE 284 MARKET: PRODUCT LAUNCHES, JANUARY 2020-MAY 2023
12.8.2 DEALS
TABLE 285 MARKET: DEALS, JANUARY 2020-MAY 2023
12.8.3 EXPANSIONS
TABLE 286 SINGLE CELL ANALYSIS MARKET: EXPANSIONS, JANUARY 2020-MAY 2023

13 COMPANY PROFILES (Page No. - 266)
(Business Overview, Products/Solutions/Services Offered, Recent Developments, MnM view (Key strengths/Right to win, Strategic choices made, Weakness/competitive threats)*
13.1 KEY COMPANIES
13.1.1 BECTON, DICKINSON AND COMPANY
TABLE 287 BECTON, DICKINSON AND COMPANY: COMPANY OVERVIEW
FIGURE 38 BECTON, DICKINSON AND COMPANY: COMPANY SNAPSHOT (2022)
13.1.2 DANAHER CORPORATION
TABLE 288 DANAHER CORPORATION: COMPANY OVERVIEW
FIGURE 39 DANAHER CORPORATION: COMPANY SNAPSHOT (2022)
13.1.3 MERCK KGAA
TABLE 289 MERCK KGAA: COMPANY OVERVIEW
FIGURE 40 MERCK KGAA: COMPANY SNAPSHOT (2022)
13.1.4 THERMO FISHER SCIENTIFIC, INC.
TABLE 290 THERMO FISHER SCIENTIFIC, INC.: COMPANY OVERVIEW
FIGURE 41 THERMO FISHER SCIENTIFIC: COMPANY SNAPSHOT (2022)
13.1.5 QIAGEN N.V.
TABLE 291 QIAGEN N.V.: COMPANY OVERVIEW
FIGURE 42 QIAGEN N.V.: COMPANY SNAPSHOT (2022)
13.1.6 10X GENOMICS
TABLE 292 10X GENOMICS: COMPANY OVERVIEW
FIGURE 43 10X GENOMICS: COMPANY SNAPSHOT (2022)
13.1.7 ILLUMINA, INC.
TABLE 293 ILLUMINA, INC.: COMPANY OVERVIEW
FIGURE 44 ILLUMINA, INC.: COMPANY SNAPSHOT (2022)
13.1.8 BIO-RAD LABORATORIES
TABLE 294 BIO-RAD LABORATORIES: COMPANY OVERVIEW
FIGURE 45 BIO-RAD LABORATORIES: COMPANY SNAPSHOT (2022)
13.1.9 PROMEGA CORPORATION
TABLE 295 PROMEGA CORPORATION: COMPANY OVERVIEW
13.1.10 STANDARD BIOTOOLS
TABLE 296 STANDARD BIOTOOLS: COMPANY OVERVIEW
FIGURE 46 STANDARD BIOTOOLS: COMPANY SNAPSHOT (2022)
13.1.11 AGILENT TECHNOLOGIES, INC.
TABLE 297 AGILENT TECHNOLOGIES, INC.: COMPANY OVERVIEW
FIGURE 47 AGILENT TECHNOLOGIES, INC.: COMPANY SNAPSHOT (2022)
13.1.12 CORNING INCORPORATED
TABLE 298 CORNING INCORPORATED: COMPANY OVERVIEW
FIGURE 48 CORNING INCORPORATED: COMPANY SNAPSHOT (2022)
13.1.13 TAKARA BIO INC.
TABLE 299 TAKARA BIO INC.: COMPANY OVERVIEW
FIGURE 49 TAKARA BIO INC.: COMPANY SNAPSHOT (2022)
13.1.14 BIOMÉRIEUX SA
TABLE 300 BIOMÉRIEUX SA.: COMPANY OVERVIEW
FIGURE 50 BIOMÉRIEUX SA: COMPANY SNAPSHOT (2022)
13.1.15 TECAN GROUP LTD.
TABLE 301 TECAN GROUP LTD.: COMPANY OVERVIEW
FIGURE 51 TECAN GROUP LTD.: COMPANY SNAPSHOT (2022)
13.1.16 SARTORIUS AG
TABLE 302 SARTORIUS AG: COMPANY OVERVIEW
FIGURE 52 SARTORIUS AG: COMPANY SNAPSHOT (2022)
13.1.17 DIASORIN S.P.A.
TABLE 303 DIASORIN S.P.A.: COMPANY OVERVIEW
FIGURE 53 DIASORIN S.P.A.: COMPANY SNAPSHOT (2022)
13.2 OTHER PLAYERS
13.2.1 OXFORD NANOPORE TECHNOLOGIES PLC
13.2.2 CYTEK BIOSCIENCES
13.2.3 FLUXION BIOSCIENCES INC.
13.2.4 MENARINI SILICON BIOSYSTEMS
13.2.5 APOGEE FLOW SYSTEMS LTD.
13.2.6 NANOCELLECT BIOMEDICAL
13.2.7 ON-CHIP BIOTECHNOLOGIES CO., LTD.
13.2.8 RARECYTE, INC.
*Details on Business Overview, Products/Solutions/Services Offered, Recent Developments, MnM view (Key strengths/Right to win, Strategic choices made, Weakness/competitive threats)* might not be captured in case of unlisted companies.

14 APPENDIX (Page No. - 337)
14.1 DISCUSSION GUIDE
14.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
14.3 CUSTOMIZATION OPTIONS
14.4 RELATED REPORTS
14.5 AUTHOR DETAILS